10X Genomics Inc Class A (TXG)

R&D Expenses

$226.80M

TTM · Period ending: · USD

TXG logo

TXG R&D Expenses

Latest reported$226.80M
TXG TTM R&D Expenses ($50.40M → $226.80M)
High-resolution chart · PNG

TXG r&d expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

10X Genomics Inc Class A R&D Expenses — Trailing twelve months (TTM) (USD)
Period endingR&D Expenses (USD)
226,801,000
231,234,000
238,632,000
249,631,000
258,611,000
260,305,000
264,698,000
262,997,000
304,732,000
313,274,000
311,734,000
310,081,000
269,462,000
268,687,000
265,667,000
263,938,000
251,230,000
233,947,000
211,752,000
189,572,000
165,133,000
139,266,000
123,375,000
111,559,000
103,625,000
94,124,000
83,097,000
68,288,000
57,164,000
50,574,000
50,398,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.